服用缓释氨茶碱的支气管哮喘患者所记录的主观和客观变化。
Subjective and objective changes noted by patients with bronchial asthma taking slow-release aminophylline.
作者信息
Nicholson E M, Laszlo G
出版信息
J Int Med Res. 1979;7 Suppl 1:32-3.
PMID:374161
Abstract
The authors describe a placebo controlled trial of a slow-release form of aminophylline in a total of twenty asthmatic patients. The data resulting from this work confirmed the fact that the aminophylline is a bronchodilator which improves mean peak flow rate and reduces the intake of beta-agonist drugs in the majority of asthmatic patients.
摘要
作者描述了一项针对20名哮喘患者的氨茶碱缓释剂型的安慰剂对照试验。这项研究得出的数据证实了氨茶碱是一种支气管扩张剂，它能提高大多数哮喘患者的平均峰值流速并减少β-激动剂药物的摄入量。
Zotero 插件